Stage IV Lung Cancer: Carla's Patient Story
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Sex
- Female
- Spread to
- brain
- Treatment
- targeted therapy, chemotherapy, radiation and a clinical trial
- Outcome
- Responding Well
Treatment course, step by step
- Third-line afatinib; subsequent medications, chemotherapy, and clinical trials; radiation to a brain lesion after a seizure; eighth-line treatment at the latest update.
What happened, in summary
Carla lived with lung cancer that repeatedly developed resistance to treatment. For long periods, her symptoms were limited mainly to coughing and manageable fatigue. In January 2015, while taking third-line afatinib, she married Bud and moved to Manila to begin their life together and continue her career. As one treatment stopped working, her family helped find the next medication or clinical trial and sometimes arranged access to drugs that were not available locally.
The illness became more urgent when Carla had a seizure and scans found a mass in her brain. She received brain radiation and was initially well enough to return home. Three months later, the mass had grown substantially, and fluid occupied much of the affected lung, causing breathlessness and painful drainage procedures. Her family feared they were losing her, but Carla survived the crisis and again returned to a more stable routine.
At the latest update, Carla was on her eighth line of treatment, stable, and experiencing no new symptoms. She remained active enough to attend LUNGevity’s National HOPE Summit in 2017. Throughout the repeated changes in treatment, her practical optimism, marriage, work, family support, and faith helped her continue living day by day.
Where this story comes from
This is a lay summary of an account first published by LUNGevity. Read the original in full
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team.